Time to Go Shopping for Healthcare
The decline in equity markets has created opportunities to buy a variety of healthcare stocks at attractive valuations. Insider purchases have...
359 Views
HEC ChangJiang Pharma IPO - Just a Manufacturing Shell
YiChang HEC ChangJiang Pharmaceuticals (YHCP) plans to raise US$160-215m through an issuance of primary shares in its IPO.We've worked along...
458 Views
Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling Shareholder
China Nepstar's Chairman and his China Neptunus Drugstore Holding Ltd. (54% owner) has offered $2.60/ADS to take the company private (announcement...
489 Views
China ADR Privatizations: The Challenges of Getting the Best Deal
The stellar performance of China’s stock markets over the past twelve months (Shanghai +121%, Shenzhen +161%, and Hong Kong +17%) has led to a...
559 Views
Unique biopharmaceutical company with high barrier of entry, high growth expected, take the deal
3SBio is a leading biopharmaceutical company based in China offering products including EPIAO to cure anemia in Chronic Kidney Disease (CKD),...
364 Views